Analysis of tumor RNA revealed a significant decrease in the expression of mRNAs encoding (a) angiogenic growth factors, including ANGPTL4, EPO, and placental growth factor (PGF); (b) proteins mediating immune evasion, including CD73 and PDL1; and (c) proteins with effects on both angiogenesis and immunity, including VEGFA, stroma-derived factor 1 (SDF-1; also known as CXCL12), and stem cell factor (SCF; also known as KIT ligand [KITLG]) in response to 32-134D treatment (P < 0.05; Figure 2D). This evidence concerns the gene EPO and neoplasm.